J. Waitzinger

677 total citations
22 papers, 491 citations indexed

About

J. Waitzinger is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, J. Waitzinger has authored 22 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Pharmacology. Recurrent topics in J. Waitzinger's work include Pharmacogenetics and Drug Metabolism (4 papers), Respiratory and Cough-Related Research (3 papers) and Cardiovascular Function and Risk Factors (3 papers). J. Waitzinger is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Respiratory and Cough-Related Research (3 papers) and Cardiovascular Function and Risk Factors (3 papers). J. Waitzinger collaborates with scholars based in Germany, France and Switzerland. J. Waitzinger's co-authors include Frank Bepperling, Dirk Lehnick, Thomas J. Vogl, C. Geraldine McMahon, W. Pegios, J. O. Balzer, J. F. Baron, J. Lissner, G Pirovano and Siegfried Wieshammer and has published in prestigious journals such as Neurology, Journal of Allergy and Clinical Immunology and European Heart Journal.

In The Last Decade

J. Waitzinger

22 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Waitzinger Germany 10 140 124 79 77 77 22 491
Nicola Vitturi Italy 12 161 1.1× 74 0.6× 59 0.7× 152 2.0× 28 0.4× 39 509
Κ Katogiannis Greece 14 141 1.0× 69 0.6× 258 3.3× 96 1.2× 50 0.6× 59 619
Patricia A. C. Specht Netherlands 13 41 0.3× 98 0.8× 150 1.9× 101 1.3× 33 0.4× 28 639
Maria Fitzgibbon Ireland 14 184 1.3× 18 0.1× 158 2.0× 141 1.8× 47 0.6× 36 645
Connie P. C. Ow Australia 13 28 0.2× 48 0.4× 57 0.7× 84 1.1× 58 0.8× 25 491
Lasse Bent-Hansen Denmark 10 150 1.1× 22 0.2× 112 1.4× 60 0.8× 15 0.2× 15 381
Georges Gilson Luxembourg 15 49 0.3× 69 0.6× 237 3.0× 103 1.3× 45 0.6× 30 946
Takeshi Motomiya Japan 15 35 0.3× 35 0.3× 255 3.2× 133 1.7× 52 0.7× 69 584
Per Ederoth Sweden 15 26 0.2× 64 0.5× 84 1.1× 82 1.1× 15 0.2× 30 516
Shyan–Yih Chou United States 17 79 0.6× 52 0.4× 245 3.1× 121 1.6× 52 0.7× 54 896

Countries citing papers authored by J. Waitzinger

Since Specialization
Citations

This map shows the geographic impact of J. Waitzinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Waitzinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Waitzinger more than expected).

Fields of papers citing papers by J. Waitzinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Waitzinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Waitzinger. The network helps show where J. Waitzinger may publish in the future.

Co-authorship network of co-authors of J. Waitzinger

This figure shows the co-authorship network connecting the top 25 collaborators of J. Waitzinger. A scholar is included among the top collaborators of J. Waitzinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Waitzinger. J. Waitzinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cawello, Willi, et al.. (2015). Effect of Age and Sex on Lacosamide Pharmacokinetics in Healthy Adult Subjects and Adults with Focal Epilepsy. Clinical Drug Investigation. 35(4). 255–265. 18 indexed citations
2.
Cawello, Willi, Erwin Surmann, & J. Waitzinger. (2012). Lacosamide Has No Effect on the Enzymatic Activity of CYP3A4 (P01.076). Neurology. 78(Meeting Abstracts 1). P01.076–P01.076. 3 indexed citations
3.
Waitzinger, J., et al.. (2010). Minimized estradiol absorption with ultra-low-dose 10 μg 17β-estradiol vaginal tablets. Climacteric. 13(3). 219–227. 87 indexed citations
4.
Siegmund, Werner, et al.. (2004). Pharmacokinetics of the selective PDE4 inhibitor Roflumilast and its active metabolite Roflumilast N-oxide are not affected by concomitant budesonide, salbutamol, or erythromycin. Journal of Allergy and Clinical Immunology. 113(2). S222–S222. 1 indexed citations
5.
Waitzinger, J., et al.. (2003). Hydroxyethyl Starch (HES) [130/0.4],??? a New HES Specification. Drugs in R&D. 4(3). 149–157. 55 indexed citations
6.
Cawello, Willi, et al.. (2002). Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition. International Journal of Clinical Pharmacology and Therapeutics. 40(1). 9–17. 8 indexed citations
7.
Waitzinger, J., et al.. (2001). Comparative Bioavailability Study of Two Different Nimesulide-Containing Preparations Available on the Italian Market. Clinical Drug Investigation. 21(5). 361–369. 6 indexed citations
8.
Waitzinger, J., et al.. (1999). Safety and tolerability of naproxen ophthalmic solution in comparison to placebo.. PubMed. 37(3). 133–40. 5 indexed citations
9.
Vree, T.B., et al.. (1999). Absolute bioavailability, pharmacokinetics, renal and biliary clearance of distigmine after a single oral dose in comparison to i.v. administration of 14C-distigmine-bromide in healthy volunteers.. PubMed. 37(8). 393–403. 14 indexed citations
10.
Bepperling, Frank, et al.. (1999). HES 130/0.4, a new HES specification: pharmacokinetics after multiple infusions of 10% solutions in healthy volunteers. Critical Care. 3(Suppl 1). P154–P154. 7 indexed citations
11.
Waitzinger, J., et al.. (1999). Effect of a New Hydroxyethyl Starch (HES) Specification [6% HES (130/0.4)] on Blood and Plasma Volumes after Bleeding in 12 Healthy Male Volunteers. Clinical Drug Investigation. 17(2). 119–125. 24 indexed citations
12.
13.
Waitzinger, J., et al.. (1996). Bioequivalence evaluation of two preparations containing the highly variable compound selegiline (L-deprenyl).. PubMed. 34(10). 427–32. 6 indexed citations
14.
Waitzinger, J., et al.. (1994). Radio Labelling of Drugs in a Metered Dose Inhaler (MDI) and Lung Deposition in Human Subjects. Journal of Aerosol Medicine. 7(2). 173–176. 3 indexed citations
15.
Pegios, W., et al.. (1992). Kernspintomographie der Leber mit dem neuen Kontrastmittel. Gd-BOPTA Ergebnisse einer In-vivo-Phase-I-Prüfung. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 156(5). 465–470. 4 indexed citations
16.
Vogl, Thomas J., W. Pegios, C. Geraldine McMahon, et al.. (1992). Gadobenate dimeglumine--a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers.. American Journal of Roentgenology. 158(4). 887–892. 81 indexed citations
17.
Wieshammer, Siegfried, F. S. Keck, J. Waitzinger, et al.. (1989). Acute hypothyroidism slows the rate of left ventricular diastolic relaxation. Canadian Journal of Physiology and Pharmacology. 67(9). 1007–1010. 42 indexed citations
18.
Wieshammer, Siegfried, J. Waitzinger, J. Köhler, et al.. (1988). Left ventricular function at rest and during exercise in acute hypothyroidism.. Heart. 60(3). 204–211. 26 indexed citations
19.
Stauch, M., Georg Großmann, André Schmidt, et al.. (1987). Effect of gallopamil on left ventricular function in regions with and without ischaemia. European Heart Journal. 8(suppl G). 77–83. 10 indexed citations
20.
Henze, E., et al.. (1987). Tumor scintigraphy with 131I anti CEA monoclonal antibodies and F(ab?)2 in colorectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. 13(3). 125–129. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola Vitturi Breakdown of academic impact, for papers by Κ Katogiannis Breakdown of academic impact, for papers by Patricia A. C. Specht Breakdown of academic impact, for papers by Maria Fitzgibbon Breakdown of academic impact, for papers by Connie P. C. Ow Breakdown of academic impact, for papers by Lasse Bent-Hansen Breakdown of academic impact, for papers by Georges Gilson Breakdown of academic impact, for papers by Takeshi Motomiya Breakdown of academic impact, for papers by Per Ederoth Breakdown of academic impact, for papers by Shyan–Yih Chou
Rankless by CCL
2026